Crosstalk between hemostasis inhibitors and cholesterol biomarkers in multiple sclerosis

Crosstalk between hemostasis inhibitors and cholesterol biomarkers in multiple sclerosis

The individual roles of cholesterol pathway biomarkers (CPB) and hemostasis inhibitors with neuroimaging outcomes were previously investigated in multiple sclerosis (MS). The purpose of this extension study was to investigate potential crosstalk between plasma CPB [total cholesterol (TC), low-densi...

Full description

Bibliographic Details
Main Authors: Robert Parambi, Nicole Ziliotto, Francesco Bernardi, Marcello Baroni, Richard W Browne, Dejan Jakimovski, Bianca Weinstock-Guttman, Robert Zivadinov, Murali Ramanathan
Format: Article
Language:English
Published: PAGEPress Publications 2022-10-01
Series:Bleeding, Thrombosis and Vascular Biology
Subjects:
Cholesterol
apolipoprotein
heparin cofactor II
hemostasis inhibitor
anticoagulant
multiple sclerosis
Online Access:https://btvb.org/btvb/article/view/41

Internet

https://btvb.org/btvb/article/view/41

Similar Items